Evidence map›Paper›PMID 42531722›Full record

ArticleEBioMedicine2026

Urinary proteomic signature of exercise intolerance in patients at risk of heart failure: evidence from the HOMAGE trial.

Chu-Hao Liu, Dries S Martens, De-Wei An, Justyna Siwy, Agnieszka Latosinska, Pierpaolo Pellicori, Job A J Verdonschot, Fozia Z Ahmed, Fang-Fei Wei, Patrick Rossignol and 15 more

Abstract read
In one paragraph

Article in EBioMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Chu-Hao LiuDepartment of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Non-Profit Research Association Alliance for the Promotion of Preventive Medicine (APPREMED), Mechelen, Belgium.
Dries S MartensCentre for Environmental Sciences, Hasselt University, Hasselt, Belgium.
De-Wei AnDepartment of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Justyna SiwyMosaiques-Diagnostics GmbH, Hannover, Germany.
Agnieszka LatosinskaMosaiques-Diagnostics GmbH, Hannover, Germany.
Pierpaolo PellicoriSchool of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
Job A J VerdonschotDepartment of Cardiology, Maastricht University Medical Centre, Maastricht, the Netherlands.
Fozia Z AhmedDivision of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, UK.
Fang-Fei WeiDepartment of Cardiology, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Patrick RossignolUniversité de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU Nancy, F-CRIN INI-CRCT, Nancy, France.
Johannes PetutschniggDepartment of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité University Medicine Berlin, Berlin Institute of Health and German Centre for Cardiovascular Research, Berlin, Germany.
Stephane HeymansDepartment of Cardiology, Maastricht University Medical Centre, Maastricht, the Netherlands.
Joe J CuthbertDepartment of Cardiology, University of Hull, Castle Hill Hospital, East Riding of Yorkshire, Cottingham, UK.
Yu-Ling YuNon-Profit Research Association Alliance for the Promotion of Preventive Medicine (APPREMED), Mechelen, Belgium; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Nicolas GirerdUniversité de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU Nancy, F-CRIN INI-CRCT, Nancy, France.
Andrew L ClarkDepartment of Cardiology, University of Hull, Castle Hill Hospital, East Riding of Yorkshire, Cottingham, UK.
Peter VerhammeDepartment of Cardiovascular Sciences, Centre for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium.
Dong-Yan ZhangDepartment of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yan LiDepartment of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Tim S NawrotCentre for Environmental Sciences, Hasselt University, Hasselt, Belgium; Research Unit Environment and Health, Department of Public Health and Primary Care, University of Leuven, Leuven, Belgium.
John G ClelandSchool of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
Faiez ZannadUniversité de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU Nancy, F-CRIN INI-CRCT, Nancy, France.
Harald MischakMosaiques-Diagnostics GmbH, Hannover, Germany.
Jan A StaessenDepartment of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Non-Profit Research Association Alliance for the Promotion of Preventive Medicine (APPREMED), Mechelen, Belgium; First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland; Biomedical Science Group, University of Leuven, Leuven, Belgium. Electronic address: jan.staessen@appremed.org.
HOMAGE investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUrinary proteomic profiling (UPP) provides insights in disease mechanisms and origin of symptoms. Using UPP, this study aimed at deepening insight in the biology of exercise tolerance.

methodsIn the HOMAGE trial, 268 patients at risk of heart failure underwent the incremental shuttle walk test (SWT) and UPP by capillary electrophoresis coupled with mass spectrometry at baseline (discovery) and the 9-month final visit (replication). Sequencing of 1498 urinary peptides identified 170 non-collagen and 40 collagen-derived proteins. Ten exercise-related variables, including heart rate and blood pressure responses, symptoms and walking distance were summarised into a single factor, higher values indicating exercise intolerance. In exploratory analyses, exercise intolerance was related to the UPP, first in linear and logistic regression models, considering one peptide at a time, and next by elastic net regression considering the peptides retained in the previous step. Replicated proteins were subjected to pathway analysis.

findingsTwenty-nine non-collagen and 31 collagen-derived peptides were associated with reduced exercise capacity with correction for multiple testing. In elastic net regression, exercise intolerance was in >50% of 1000 bootstrap runs associated with the non-collagen proteins FXYD2, GAPDH, HBB, KCNB1, MB, MYOCD, SECTM1, SNX9, TACC3, TMSB4X, and TTN and with collagens COL5A1, COL6A1, COL11A2, and COL28A1. Enriched pathways involved oxygen homoeostasis, oxidative stress regulation, metabolic and developmental processes, and muscle biology.

interpretationIn HOMAGE patients, UPP identified parent proteins regulating exercise endurance, which are involved in oxygenation, vascular and muscle structure and function, maintenance of the circulating volume, and protection against oxidative stress.

fundingEuropean Union.

Indexed as

Exercise ToleranceHeart FailureProteomeProteomicsAgedBiomarkersFemaleHumansMaleMiddle AgedBiomarkersProteomeExerciseHeart failureIncremental shuttle walk testSystems biologyUrinary proteomics

Identifiers

PMID42531722
PMCPMC13452233

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.